Intranasal CRMP2-Ubc9 Inhibitor Regulates NaV1.7 to Alleviate Trigeminal Neuropathic Pain
Santiago Loya‐López, Heather N. Allen, Paz Duran, Aida Calderón‐Rivera, Kimberly Gómez, Upasana Kumar, Rory Shields, Rui Zeng, Akshat Dwivedi, Saumya Saurabh, Olga Anna Korczeniewska, Rajesh Khanna
The paper develops a CRMP2-Ubc9 inhibitor that reduces NaV1.7 activity and alleviates trigeminal neuropathic pain in rats.
Pain · Sep 26, 2023Peer-reviewedNeuroscience